Business Wire

Preclinical Data Demonstrate Potential of Creative Bio-Peptides’ Multi-Chemokine Receptor Antagonist RAP-103 to Provide Opioid Sparing Post-Surgical Pain Relief and Treatment ...

ROCKVILLE, Md.--(BUSINESS WIRE)--Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of ...
Business Wire

Preclinical Data Demonstrate Potential of Creative Bio-Peptides’ Multi-Chemokine Receptor Antagonist RAP-103 to Enhance Opioid Analgesia and Inhibit Opioid-derived Dependence ...

ROCKVILLE, Md.--(BUSINESS WIRE)--Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of ...
International Business Times

Creative BioTherapeutics Breathes New Hope in the Battle Against Drug-Resistant Diseases

Several breakthroughs have been made in medicine, with continuous innovations researched and conducted by scientists. Yet, drug-resistant diseases remain a silent epidemic, claiming millions of lives ...